Trial Profile
A Prospective Randomized Controlled Study to Compare the Efficacy of Combined Tenofovir Plus Telbuvidine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis B.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Mar 2016
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary) ; Tenofovir disoproxil fumarate
- Indications Hepatitis B
- Focus Therapeutic Use
- 22 Mar 2016 Status changed from withdrawn prior to enrolment to completed as reported by ClinicalTrials.gov.
- 26 Dec 2012 New trial record